Editor's Note On January 19, a federal court dismissed a lawsuit filed by the state of Texas opposing the federal vaccine mandate. This came just days after the Supreme Court also ruled to uphold the mandate “to promote and protect patient health and safety.” On January 20, CMS issued updated…
Editor's Note The Centers for Disease Control and Prevention, on January 19, released a study showing that in New York and California, both vaccination and prior infection offered protection against COVID-19, but those who had recovered from COVID-19 were less likely than vaccinated individuals to get infected during the Delta…
Editor's Note The Joint Commission announced on January 19 that beginning January 27, 2022, for applicable deemed program surveys in progress on that day, it will begin surveying to the “Omnibus COVID-19 Health Care Staff Vaccination” interim final rule published by the Centers for Medicare and Medicaid Services (CMS). As…
Editor's Note This study by researchers from Germany and South Africa finds that booster injections with mRNA vaccines failed to block the Omicron variant. This study of the first documented breakthrough infections with the Omicron variant in fully vaccinated individuals after receipt of booster vaccine doses demonstrates Omicron’s ability to…
Editor's Note This study from the Centers for Disease Control and Prevention (CDC) finds disparate monoclonal antibody (mAb) treatment of COVID-19 in Hispanic, Black, Asian, and Other race patients, compared to non-Hispanic and White patients. Differences in treatment with dexamethasone and remdesivir were less apparent. Analyzing data from 41 healthcare…
Editor's Note The Supreme Court on January 13 blocked the federal government’s COVID-19 vaccine-or-test requirement for workplaces with 100 or more employees, but the Court is allowing a vaccine mandate for healthcare workers at facilities that receive Medicaid and Medicare funds. The order covers more than 17 million healthcare workers…
Editor's Note This Israeli study finds that a third dose of the Pfizer-BioNTech vaccine was significantly associated with a lower rate of COVID-19 in healthcare workers (HCWs) over a median of 39 days of follow-up. Of 1,928 HCWs analyzed, 1,650 (85.6%) received a third dose booster. During follow-up, 44 HCWs…
Editor's Note This study by researchers at the All India Institute of Medical Sciences, New Delhi, on the effectiveness of the inactivated whole virion vaccine BBV152 against COVID-19 reinfection of healthcare workers (HCWs), found a high protective effect of 86% in the fully vaccinated. Of 15,244 HCWs who participated in…
Editor's Note This study by Chinese researchers finds a high percentage of asymptomatic COVID-19 infections worldwide, which highlights the potential transmission risk of asymptomatic infections in communities. In this review and meta-analysis of 95 studies, which include nearly 30 million individuals undergoing testing, the percentage of asymptomatic infections was 0.25%…
Editor's Note This case-controlled study by researchers from White River Junction Veterans Affairs Medical Center, White River Junction, Vermont, and Dartmouth School of Medicine, Hanover, New Hampshire, finds that mRNA vaccine effectiveness against COVID-19 decreases significantly after about 6 months. In this analysis of 14,238 male veterans aged 65 or…